Literature DB >> 6189859

Biochemical and immunologic analysis of hereditary myeloperoxidase deficiency.

W M Nauseef, R K Root, H L Malech.   

Abstract

Myeloperoxidase (MPO), a heme enzyme present in the azurophilic granules of human polymorphonuclear neutrophils (PMN), is important in the oxygen-dependent microbicidal activity of PMN. MPO deficiency, defined as the lack of PMN peroxidative activity, is a common genetic defect of human PMN. The purpose of our study was to characterize the structural basis for this loss of enzymatic activity, using protein biochemical and immunochemical techniques to examine PMN from three subjects with partial MPO deficiency and from five subjects with complete MPO deficiency.We purified MPO from normal PMN and defined its electrophoretic mobility after two-dimensional electrophoretic separation, using nondenaturing acidic polyacrylamide gel electrophoresis (PAGE) followed by sodium dodecyl sulfate (SDS) denaturation and SDS-PAGE separation of MPO subunit peptides. In agreement with previous studies, we found that normal MPO had subunits of 59,000 and 13,500 mol wt when subjected to SDS-PAGE under reducing conditions. Granule protein extracts of normal PMN, partially MPO-deficient PMN, and completely MPO-deficient PMN were analyzed with two-dimensional PAGE. Partially MPO-deficient PMN granules contained electrophoretically normal MPO in less than normal amounts, whereas completely MPO-deficient PMN granules contain no protein with the electrophoretic mobility of normal MPO. Using rabbit antiserum against purified MPO, we used immunoautoradiographic analysis to examine whole PMN for peptides immunochemically related to MPO. PMN from normal, partially MPO-deficient, and completely MPO-deficient subjects were solubilized in SDS and component peptides separated by SDS-PAGE. The peptides were electroblotted onto nitrocellulose paper that was exposed sequentially to rabbit anti-MPO and (125)I-protein A before autoradiography. Radiolabeled bands were identical when partially purified MPO or normal PMN were compared except that whole PMN contained a small amount of an immunologically cross-reactive membrane associated material of 75,000-90,000 mol wt. Using a modification of this immunoautoradiographic analysis, we quantitated the relative amounts of MPO peptides in PMN. PMN from MPO-deficient subjects contain 41.0-52.3% the amount of MPO peptides present in normal PMN. Similar analysis showed that completely MPO-deficient PMN lacked any peptides corresponding to MPO peptides.We conclude that partial MPO deficiency is characterized by the presence of electrophoretically and immunologically normal MPO in amounts approximately one-half that seen in PMN from normal subjects. Completely MPO-deficient PMN lack any normal MPO peptides. No MPO-deficient subject studied had an immunologically cross-reacting variant of MPO. Since this deficiency is associated with the absence of more than one peptide, it is possible that the underlying genetic defect may involve: (a) failure to synthesize a single precursor peptide; (b) abnormal regulation of the synthesis of two separate peptides; or (c) an aberration in postsynthetic processing or packaging into azurophilic granules.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6189859      PMCID: PMC436991          DOI: 10.1172/jci110880

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  33 in total

1.  Polymorphonuclear leukocyte myeloperoxidase deficiency in a patient with myelomonocytic leukemia.

Authors:  A T Davis; R D Brunning; P G Quie
Journal:  N Engl J Med       Date:  1971-09-30       Impact factor: 91.245

2.  Refractory megaloblastic anemia with myeloperoxidase-deficient neutrophils.

Authors:  R I Lehrer; L S Goldberg; M A Apple; N P Rosenthal
Journal:  Ann Intern Med       Date:  1972-03       Impact factor: 25.391

3.  A case with hematological abnormality characterized by the absence of peroxidase activity in blood polymorphonuclear leukocytes.

Authors:  O Higashi; N Katsuyama; R Satodate
Journal:  Tohoku J Exp Med       Date:  1965-10-25       Impact factor: 1.848

4.  Myeloperoxidase deficiency. Immunologic study of a genetic leukocyte defect.

Authors:  S E Salmon; M J Cline; J Schultz; R I Lehrer
Journal:  N Engl J Med       Date:  1970-01-29       Impact factor: 91.245

5.  [The Alius-Grignaschi anomaly: the hereditary constitutional peroxidase defect of the neutrophils and monocytes].

Authors:  E Undritz
Journal:  Blut       Date:  1966-12

6.  The early stages of absorption of injected horseradish peroxidase in the proximal tubules of mouse kidney: ultrastructural cytochemistry by a new technique.

Authors:  R C Graham; M J Karnovsky
Journal:  J Histochem Cytochem       Date:  1966-04       Impact factor: 2.479

7.  Role of the phagocyte in host-parasite interactions. XII. Hydrogen peroxide-myeloperoxidase bactericidal system in the phagocyte.

Authors:  R J McRipley; A J Sbarra
Journal:  J Bacteriol       Date:  1967-11       Impact factor: 3.490

8.  Myeloperoxidase: contribution to the microbicidal activity of intact leukocytes.

Authors:  S J Klebanoff
Journal:  Science       Date:  1970-09-11       Impact factor: 47.728

9.  Leukocyte myeloperoxidase deficiency and disseminated candidiasis: the role of myeloperoxidase in resistance to Candida infection.

Authors:  R I Lehrer; M J Cline
Journal:  J Clin Invest       Date:  1969-08       Impact factor: 14.808

10.  Iodination of bacteria: a bactericidal mechanism.

Authors:  S J Klebanoff
Journal:  J Exp Med       Date:  1967-12-01       Impact factor: 14.307

View more
  19 in total

1.  Purification of myeloperoxidase from equine polymorphonuclear leucocytes.

Authors:  M Mathy-Hartert; E Bourgeois; S Grülke; G Deby-Dupont; I Caudron; C Deby; M Lamy; D Serteyn
Journal:  Can J Vet Res       Date:  1998-04       Impact factor: 1.310

Review 2.  What really happens in the neutrophil phagosome?

Authors:  James K Hurst
Journal:  Free Radic Biol Med       Date:  2012-05-15       Impact factor: 7.376

3.  Myeloperoxidase is increased in human cerebral aneurysms and increases formation and rupture of cerebral aneurysms in mice.

Authors:  Yi Chu; Katina Wilson; He Gu; Lauren Wegman-Points; Sarah A Dooley; Gary L Pierce; Guangjie Cheng; Ricardo A Pena Silva; Donald D Heistad; David Hasan
Journal:  Stroke       Date:  2015-04-28       Impact factor: 7.914

4.  Studies on the subunits of human myeloperoxidase.

Authors:  R L Olsen; C Little
Journal:  Biochem J       Date:  1984-09-15       Impact factor: 3.857

5.  Characterization of cDNA clones for human myeloperoxidase: predicted amino acid sequence and evidence for multiple mRNA species.

Authors:  K R Johnson; W M Nauseef; A Care; M J Wheelock; S Shane; S Hudson; H P Koeffler; M Selsted; C Miller; G Rovera
Journal:  Nucleic Acids Res       Date:  1987-03-11       Impact factor: 16.971

6.  Vascular peroxidase-1 is rapidly secreted, circulates in plasma, and supports dityrosine cross-linking reactions.

Authors:  Guangjie Cheng; Hong Li; Zehong Cao; Xiaoyun Qiu; Sally McCormick; Victor J Thannickal; William M Nauseef
Journal:  Free Radic Biol Med       Date:  2011-07-12       Impact factor: 7.376

7.  Proconvertase proteolytic processing of an enzymatically active myeloperoxidase precursor.

Authors:  Sally McCormick; Angela Nelson; William M Nauseef
Journal:  Arch Biochem Biophys       Date:  2012-08-10       Impact factor: 4.013

8.  Cytochemically unreactive neutrophils from subjects with myeloperoxidase (MPO) deficiency show a complex pattern of immunoreactivity with anti-MPO monoclonal antibodies: a flow cytometric and immunocytochemical study.

Authors:  F Lanza; A Latorraca; P Musto; L Ferrari; S Moretti; G Zabucchi; M Carotenuto; G L Castoldi
Journal:  Ann Hematol       Date:  1991-08       Impact factor: 3.673

9.  Self-labeling of human polymorphonuclear leucocyte myeloperoxidase with 125iodine.

Authors:  G Deby-Dupont; J Pincemail; A Thirion; C Deby; M Lamy; P Franchimont
Journal:  Experientia       Date:  1991-09-15

10.  Myeloperoxidase deficiency: an epidemiological study and flow-cytometric detection of other granular enzymes in myeloperoxidase-deficient subjects.

Authors:  R Becker; K H Pflüger
Journal:  Ann Hematol       Date:  1994-10       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.